Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2017 Filed Aug 4, 2017 17:01 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 65,861 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-17-011152 · edgar.xml · derivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,169 Underlying: Common stock · 65,861 shares Expires 2024-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 17:01 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 35 | $71.01 | $2,485.18 |
DisclosureSEC source: 0001179110-17-011152 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,530 Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 17:01 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 65,826 | $71.00 | $4,673,646.00 |
DisclosureSEC source: 0001179110-17-011152 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,565 Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 17:01 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Exercise / conversionCommon stock, $0.01 par value | 65,861 | $51.42 | $3,386,572.62 |
DisclosureSEC source: 0001179110-17-011152 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
RAPP EDWARD JDirector
|
PurchaseCommon Stock, $0.01 par value | 4,000 | $70.45 | $281,782.00 |
DisclosureSEC source: 0001179110-17-010981 · edgar.xml · nonDerivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,498 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.34 | $7,034.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 29 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,737 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.29 | $7,029.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 28 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,837 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 200 | $70.25 | $14,050.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 27 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,937 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 600 | $70.23 | $42,138.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 26 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,137 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 400 | $70.22 | $28,088.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 25 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,737 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 700 | $70.21 | $49,147.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 24 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,137 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 500 | $70.20 | $35,100.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 23 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,837 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 1,200 | $70.19 | $84,228.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 22 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,337 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 300 | $70.19 | $21,055.50 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 21 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,537 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 500 | $70.18 | $35,090.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 20 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,837 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 200 | $70.18 | $14,035.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 19 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,337 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 400 | $70.17 | $28,068.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 18 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,537 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 600 | $70.16 | $42,096.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 17 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,937 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.15 | $7,015.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 16 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,537 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.14 | $7,014.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 15 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,637 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 800 | $70.13 | $56,104.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 14 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,737 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 700 | $70.12 | $49,084.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 13 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,537 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 200 | $70.12 | $14,023.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 12 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,237 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 1,000 | $70.11 | $70,110.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 11 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,437 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 400 | $70.10 | $28,040.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 10 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,437 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.09 | $7,009.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 9 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,837 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.08 | $7,008.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 8 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,937 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 400 | $70.07 | $28,028.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 7 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,037 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.05 | $7,005.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 6 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,437 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 300 | $70.04 | $21,012.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 5 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,537 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 600 | $70.02 | $42,012.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 4 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,837 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 1,537 | $70.01 | $107,605.37 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 3 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,437 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 100 | $70.01 | $7,000.50 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 2 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,974 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:05 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 5,663 | $70.00 | $396,410.00 |
DisclosureSEC source: 0001179110-17-010982 · edgar.xml · nonDerivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,074 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:06 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, $0.01 par value | 200 | $70.45 | $14,090.00 |
DisclosureSEC source: 0001179110-17-010983 · edgar.xml · nonDerivative · entry 2 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,437 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:06 UTC |
Gosebruch Henry OChief Strategy Officer
|
SaleCommon stock, par value $0.01 | 100 | $70.37 | $7,037.00 |
DisclosureSEC source: 0001179110-17-010983 · edgar.xml · nonDerivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,637 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 15:39 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 451 | $72.51 Strike: $0.00 | $32,702.01 |
DisclosureSEC source: 0001179110-17-009954 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,498 Underlying: Common Stock · 451 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 11:39 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 430 | $72.51 Strike: $0.00 | $31,179.30 |
DisclosureSEC source: 0001179110-17-009955 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,688 Underlying: Common stock · 430 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 11:40 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 517 | $72.51 Strike: $0.00 | $37,487.67 |
DisclosureSEC source: 0001179110-17-009956 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,970 Underlying: Common Stock · 517 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 15:40 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 90 | $72.51 Strike: $0.00 | $6,525.90 |
DisclosureSEC source: 0001179110-17-009957 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,491 Underlying: Common Stock · 90 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 27, 2017 Filed Jun 30, 2017 17:06 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 2,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-009834 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,492 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Exercise / conversionOption (right to buy) · Derivative | 45,800 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0001179110-17-009114 · edgar.xml · derivative · entry 4 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 45,800 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
SaleCommon stock, $0.01 par value | 45,800 | $70.00 | $3,206,000.00 |
DisclosureSEC source: 0001179110-17-009114 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,745 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Exercise / conversionCommon stock, $0.01 par value | 45,800 | $24.21 | $1,108,735.56 |
DisclosureSEC source: 0001179110-17-009114 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 79,800 | $0.00 Strike: $29.23 | $0.00 |
DisclosureSEC source: 0001179110-17-009115 · edgar.xml · derivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 79,800 shares Expires 2022-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon stock, $0.01 par value | 79,800 | $70.00 | $5,586,000.00 |
DisclosureSEC source: 0001179110-17-009115 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,825 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 21:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon stock, $0.01 par value | 79,800 | $29.23 | $2,332,274.70 |
DisclosureSEC source: 0001179110-17-009115 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 21:04 UTC |
SEVERINO MICHAELEVP, R&D and CSO
|
Tax withholdingCommon stock, $0.01 par value | 21,576 | $66.71 | $1,439,334.96 |
DisclosureSEC source: 0001179110-17-008576 · edgar.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · EVP, R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,555 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 1,100 | $65.52 | $72,066.50 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,727 Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:13 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 1,300 | $65.51 | $85,163.00 |
DisclosureSEC source: 0001179110-17-007862 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,827 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.